Sign In

Tobias Silberzahn

Partner at McKinsey & Company

Professional Background

Tobias Silberzahn is an accomplished Partner at McKinsey & Company, leading efforts within the Berlin office's esteemed Pharma & MedTech Practice and Innovation Practice. With over a decade of experience within McKinsey, Tobias has developed a rich specialization in the health tech sector, working with pharmaceutical firms, medical device companies, and ministries of health around the globe. Tobias's impressive leadership extends beyond his client engagements; he is at the forefront of McKinsey's global Health Tech Network, which encompasses a vast community of more than 700 digital health companies that are pioneering the future of healthcare.

With a focus on healthcare innovation and health-tech business building, Tobias adeptly guides his clients through pivotal challenges in research and development (R&D), commercialization, and business scaling. He is highly regarded for his ability to foster innovation and drive success in the ever-evolving health tech landscape.

In addition to his primary responsibilities, Tobias passionately hosts the McKinsey MedTech R&D Roundtable and the Pharma Technical Development Forum. These initiatives are designed to facilitate knowledge sharing and collaborative problem-solving among industry leaders in R&D, enabling advancements in medical technology and pharmaceuticals that positively impact patient outcomes.

Education and Achievements

Tobias's educational journey laid a solid foundation for his career in health tech and pharmaceuticals. He pursued a Diploma in Biochemistry at the prestigious University of Tübingen, which afforded him an in-depth understanding of biochemical processes vital in the health sector. His academic rigor continued with a scientific year at the esteemed Max Planck Institute for Biochemistry in Martinsried, Germany, where he engaged in cutting-edge research under the auspices of the Max Planck Society.

Further showcasing his dedication to scientific excellence, Tobias earned his PhD in Immunology at King’s College London, one of the world's leading research institutions. This advanced study sharpened his expertise in immunology, further enhancing his ability to navigate complex health challenges faced in the pharmaceutical and biotech industries.

Notable Memberships and Contributions

Tobias serves as a prominent member of SCIANA, also known as the Health Leaders Network. This network consists of forward-thinking health leaders who collaborate to reshape the future of healthcare through innovative ideas and shared expertise. Tobias’s involvement in SCIANA reflects his commitment to leadership and collaboration within the health tech industry, providing valuable insights and fostering connections that will influence the growth of health tech initiatives worldwide.

Additionally, Tobias's previous roles as a scientist in immuno-oncology at the Institute of Immunology, University of Tübingen, and his work in influenza research at the Friedrich-Loeffler Institute have solidified his position as a thought leader in the intersection of health, science, and technology. His collective experiences have equipped him with a comprehensive understanding of the scientific principles that drive innovation in healthcare.

With a keen focus on nurturing the next wave of health tech innovation, Tobias extends an invitation to health tech CEOs and founders interested in joining the McKinsey Health Tech Network. This community provides opportunities for like-minded professionals to network, collaborate, and tackle the most pressing challenges facing the healthcare industry today. For those interested, joining is free of charge, and details can be found here: McKinsey Health Tech Network Sign-Up.

tags(['Health Tech', 'Pharmaceuticals', 'Medical Devices', 'Healthcare Innovation', 'McKinsey & Company', 'Health Leaders Network', 'R&D', 'Biochemistry', 'Immunology', ' Digital Health', 'Health Tech Network', 'Health Sector Leadership'])

questions(['How did Tobias Silberzahn develop his expertise in healthcare innovation and health tech?','What inspired Tobias Silberzahn to join McKinsey & Company and focus on the Pharma & MedTech Practice?','How has Tobias Silberzahn contributed to the global Health Tech Network during his tenure at McKinsey?', 'What experiences from Tobias Silberzahn’s academic background have most influenced his career in health tech and pharmaceuticals?', 'What key trends in digital health does Tobias Silberzahn foresee impacting the future of the healthcare industry?'])} negó a a b , c a a a t t í    c  a t t f c a u n a t t p u e a - orte a c e e c af e -r a r fgr e b fgr t e - a -a a e - ı e - b n - p n - x u e - i n - - n - - j f ai spk s o ́ r e ́ a## . o rt p f e s au t s r l t a z o e u o - - e b e e

Highlights

May 23 · linkedin

Vereint für Demokratie! Die zunehmenden Bedrohungen und Angriffe auf staatliche Vertreter:innen, aber auch auf engagierte Bürger:innen zeigen: 75 Jahre nach Verkündung des Grundgesetzes ist unsere Demokratie in Gefahr. Jetzt kommt es nicht nur darauf an, Haltung zu zeigen, sondern uns aktiv am Schutz unserer Demokratie mitzuwirken.

🙌 Deshalb haben die Allianz Foundation und ProjectTogether den "Vereint für Demokratie Fonds" ins Leben gerufen. Mit Unterstützung des Business Council for Democracy, der Charta der Vielfalt e.V., Scholz & Friends und weiteren Partnerorganisationen aus Wirtschaft und Zivilgesellschaft.

💰Er bündelt finanzielle Mittel von Unternehmen und vergibt sie schnell und unkompliziert an Organisationen mit bewährten Ansätzen, die unsere Demokratie verteidigen. Damit diese jetzt ihre Aktivitäten ausweiten können – regional, deutschlandweit und im Netz. Eine unabhängige Jury hat heute im Allianz Forum darüber entschieden, welche Organisationen mit Mitteln des Vereint für Demokratie Fonds gefördert werden.

24 Organisationen erhalten eine sofortige Förderung. Herzlichen Glückwunsch an: Aktionsbündnis Brandenburg, Augen auf e.V. Oberlausitz, Colorido e. V., Correctiv gGmbH, DaMOst e.V., Dorfbewegung Brandenburg, Fack e. V., FFF - Reclaim TikTok, Gesellschaft für Freiheitsrechte e. V., Hate Aid gGmbH, Jugendstil*, Junge Islam Konferenz, Kulturbüro Sachsen e. V., Lernort Stadion e. V., Media Force, Mehr Demokratie! e. V., MigraNetz Thüringen e. V., Omas gegen Rechts Erfurt e. V., Rosalinde Leipzig e. V., SISTERS*, Solidarische Vernetzung Sachsen, Stadtlandgestalten Altenburg, Weltoffenes Thüringen, zedela.

Weitere acht Organisationen stehen auf der Warteliste und erhalten eine Förderung, bei weiteren Einzahlungen in den Fonds: Amal Berlin / Hamburg / Frankfurt, Filmtour “Nichts mehr wie es war”, Generation Postmigration e.V., Join Politics, Plattform e.V., Politics for Tomorrow, Transformakers e.V., Wir sind der Osten gUG.

👏Der Fonds startet mit einer Summe von rund 850.000 Euro von Unternehmen und Stiftungen. Vielen, vielen Dank an alle Förderpartner:innen!

➡️ Jetzt braucht es weitere Partner:innen, die sich finanziell einbringen wollen. Denn auch Unternehmen stehen jetzt mehr denn je in der Verantwortung, die Demokratie in Deutschland zu verteidigen und zivilgesellschaftliche Initiativen zu fördern.

Erfahre mehr: https://lnkd.in/e49PibQ5

💬 Um es in den Worten von Esra Küçük, Vorständin der Allianz Foundation, zu sagen: „Der Schutz unserer Demokratie geht uns alle an – das haben die landesweiten Großdemonstrationen für Rechtsstaatlichkeit und gesellschaftlichen Zusammenhalt verdeutlicht. Deshalb freue ich mich, dass wir zusammen mit der Wirtschaft der engagierten Zivilgesellschaft vor Ort den Rücken stärken. Mit dem Fonds bringen wir Finanzierung dorthin, wo sie hier und jetzt dringend benötigt wird“.

#VereintfuerDemokratie

May 2 · linkedin

Interesting longevity event coming up in Berlin!

Tobias Silberzahn
Add to my network

Location

Berlin, Berlin, Germany